Laboratories that conduct KRAS testing

The KRAS gene may be mutated in up to 30% of lung cancer patients with adenocarcinoma histology. It is more frequently observed in patients with a smoking history. Patients with KRAS mutations may be effectively treated with medications that block some of the cellular processes that lead to cancer when the KRAS gene is mutated (e.g. MEK and mTOR inhibitors). The laboratories listed below offer testing for mutations in the KRAS gene.

Vendor Vendor Test/Assay Unique Identifier Contact Information
Baylor College of Medicine 9040 (800) 411-GENE (4363), Fax (713) 798-2787
Fox Chase Cancer Center- Clinical Molecular Genetics Laboratory KRAS (codons 12 and 13) (215) 728-4785, betsy.bove@fccc.edu
GenPath Diagnostics 5288-6 (800) 627-1479
Molecular Pathology Laboratory Network KRAS (800) 932-2943 info@mplnet.com
Ohio State University, Pathology Core Facility (PCF) KRAS mutation analysis Call Aileen @ 614-293-5292, Aileen.Carter@osumc.edu
Quest Diagnostics KRAS mutation analysis (800) 222-0446, http://www.questdiagnostics.com/hcp/contactus/hcp_contact_cust_srv.html
Response Genetics KRAS mutation (323) 224-3900, (323) 224-3096
University of Pittsburgh Medical Center- Division of Molecular Anatomic Pathology KRAS mutation (412) 647-2811

Our goal is to provide a comprehensive list of laboratories that conduct KRAS mutational analysis.

If your company conducts this test but is not listed, Email Us.

#